Title: Trends, Opportunities, and Challenges in Single-Use Systems, 3p.

Approximately 85 percent of pre-commercial biopharmaceutical manufacturing is completed with single-use systems (SUS) and the biopharmaceutical industry has seen 14-15 percent consistent annual growth over the last decade.1 Jennifer Gemo Head of the Biopharma Processing Business Csilla Kollar Technical Service & Development Scientist As the industry gains experience and confidence in utilizing these materials, SUS have become indispensable tools in the development and optimization of biopharmaceutical processes to protect against contamination, increase flexibility, and eliminate costs. This trajectory will continue to rise as the need for efficiency and cost savings in drug development and manufacturing processes increases.

Click Here For Complete Abstract Text

 

   Person Information
   Application Sequencing
Company  Product  Process  Other  Subjects  Event  Event  Date  Location  Publication  Publication  Date Text  Descriptor

  • Single-stage Centrifugal Pump

  • Single-Use Technology

 

 

 

 

  • Pharmaceutical Processing

 

  • 9/1/2018

 

  • Abstract